<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04761666</url>
  </required_header>
  <id_info>
    <org_study_id>PI2021_843_0036</org_study_id>
    <nct_id>NCT04761666</nct_id>
  </id_info>
  <brief_title>Influence of Verticalization on Bone Mineral Density and Biological Parameters of Bone Remodeling in Children With Severe Cerebral Palsy</brief_title>
  <acronym>CPABONE</acronym>
  <official_title>Influence of Verticalization on Bone Mineral Density and Biological Parameters of Bone Remodeling in Children With Severe Cerebral Palsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low bone mineral density affects 77% of children with severe cerebral palsy (GMFCS IV &amp; V)&#xD;
      with an increased fracture risk of 4%. One strategy supposed to improve bone mineral density&#xD;
      is verticalisation with static devices. Nowadays there is no time recommendation of&#xD;
      verticalisation however high intensity verticalisation has been shown to be effective in&#xD;
      improving bone mineral density in childrens with cerebral palsy, but difficult to apply in&#xD;
      real life due to lack of qualified therapists, device's complexity, and severe impairment in&#xD;
      those children. The investigators aim to compare bone mineral density and bone remodelling&#xD;
      factors of verticalized and non verticalized childrens with severe cerebral palsy as achieved&#xD;
      in everyday life. The investigators conduced a retrospective study comparing bone mineral&#xD;
      density and factors who influence bone remolling in severe cerebral palsy's according to&#xD;
      whether they are verticalized or not.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 16, 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Variation of Densitometric Z score between both groups</measure>
    <time_frame>6 months</time_frame>
    <description>A Z-score compares the patient bone density to the average bone density of people your own age and gender.A Z-score is helpful in diagnosing secondary osteoporosis and is always used for children. It is most useful when the score is less than 2 standard deviations below this normal. In this setting, it is helpful to scrutinize for coexisting illnesses or treatments that may contribute to osteoporosis such as glucocorticoid therapy, hyperparathyroidism, or alcoholism.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cerebral Palsy</condition>
  <condition>Osteoporosis</condition>
  <condition>Bone Mineral Density</condition>
  <condition>Bone Remodeling Disorder</condition>
  <condition>Fracture</condition>
  <arm_group>
    <arm_group_label>static verticalization device</arm_group_label>
    <description>children with severe cerebral palsy (GMFCS IV &amp; V) with static verticalization device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non verticalization device</arm_group_label>
    <description>children with severe cerebral palsy (GMFCS IV &amp; V) without static verticalization device</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Children whom age is between 3 and 18 years old. Children with cerebral palsy GMFCS (gross&#xD;
        motor functionnal classification scale) IV-V.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with cerebral palsy GMFCS (gross motor functional classification scale) IV-V&#xD;
&#xD;
          -  age of patients 3-18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with neuro muscular disease&#xD;
&#xD;
          -  patient age &lt; 3 years old and &gt; 18 years old&#xD;
&#xD;
          -  patient with constitutionnal bone disease&#xD;
&#xD;
          -  patient with growth hormone treatment&#xD;
&#xD;
          -  patient with surgery &lt; 6 months&#xD;
&#xD;
          -  patient with fracture &lt;3 months&#xD;
&#xD;
          -  Refusal of the legal representative&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laure Le Monnier, MD</last_name>
    <phone>0322868258</phone>
    <email>LeMonnier.Laure@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80480</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laure Le Monnier, MD</last_name>
      <phone>0322868258</phone>
      <email>LeMonnier.Laure@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 16, 2021</study_first_submitted>
  <study_first_submitted_qc>February 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2021</study_first_posted>
  <last_update_submitted>February 16, 2021</last_update_submitted>
  <last_update_submitted_qc>February 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cerebral Palsy</keyword>
  <keyword>Osteoporosis</keyword>
  <keyword>bone mineral density</keyword>
  <keyword>bone remodelling factors</keyword>
  <keyword>Fracture</keyword>
  <keyword>static verticalization device</keyword>
  <keyword>weight bearing exersices</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

